Cancer vaccine
AssigneeThe University of York
InventorRichard Birnie
Life of this patent
Estimating the term…
Abstract
We disclose a vaccine comprising a pappalysin and vaccine compositions comprising a pappalysin.
Claims11
An immunogenic composition comprising an antigenic pappalysin polypeptide fragment and an adjuvant and/or carrier, wherein the antigenic pappalysin polypeptide consists of the amino acid sequence set forth in SEQ ID NO:
- 26.
A composition comprising a nucleic acid molecule encoding an antigenic pappalysin polypeptide fragment wherein when said nucleic acid molecule is expressed the antigenic pappalysin polypeptide fragment consisting of the amino acid sequence set forth in SEQ ID NO:
- 26 is produced.
A method of vaccinating a subject suffering from or having a predisposition to cancer comprising administering an effective amount of an immunogenic composition comprising an antigenic pappalysin polypeptide fragment and an adjuvant and/or carrier wherein the antigenic pappalysin polypeptide fragment consists of the amino acid sequence set forth in SEQ ID NO:
- 26.
Dependencies are inferred from the claim text.